Form 8-K - Current report:
SEC Accession No. 0001125345-22-000108
Filing Date
2022-11-18
Accepted
2022-11-17 18:42:18
Documents
14
Period of Report
2022-11-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mgnx-20221117.htm   iXBRL 8-K 35496
2 EX-99.1 exhibit991proventiontepliz.htm EX-99.1 11368
6 image_0a.jpg GRAPHIC 12759
  Complete submission text file 0001125345-22-000108.txt   203621

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgnx-20221117.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgnx-20221117_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgnx-20221117_pre.xml EX-101.PRE 12706
8 EXTRACTED XBRL INSTANCE DOCUMENT mgnx-20221117_htm.xml XML 10821
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36112 | Film No.: 221400083
SIC: 2834 Pharmaceutical Preparations